Zions Bancorporation’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Zions Bancorporation’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-94	Closed	-$6K	–	1032
2021 Q2	$6K	Sell	94 -5	-5%	-$381	﹤0.01%	803
2021 Q1	$8K	Buy	99 +31	+46%	+$2.86K	﹤0.01%	745
2020 Q4	$7K	Buy	68 +4	+6%	+$489	﹤0.01%	738
2020 Q3	$9K	Buy	64 +61	+2,033%	+$10.2K	﹤0.01%	692
2020 Q2	$1K	Hold	3	–	–	﹤0.01%	885
2020 Q1	$0	Buy	+3	New	+$645	﹤0.01%	930

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Zions Bancorporation's LKFT Position: Q3 2021 in Review

Zions Bancorporation sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 94 shares — an estimated $6K sold.

Zions Bancorporation first reported a position in LKFT in Q1 2020 and held it in 6 quarters. The position peaked at $9K in Q3 2020. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

Zions Bancorporation reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Zions Bancorporation sold 94 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $6K.
Zions Bancorporation first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 6 quarters.
Zions Bancorporation's Lakefront Biotherapeutics American Depositary Shares position peaked at $9K in Q3 2020.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Zions Bancorporation's 13F filing for Q3 2021, filed 10 Nov 2021.